Ignyta, Inc., a biotechnology company catalyzing personalized medicine in cancer and
immunology, has acquired Actagene Oncology, Inc., a biotechnology company engaged in developing personalized medicines for cancer indications. Both the companies are ...
[Published Individual.com - 15 hours ago]